Inventor · Oissel, FR

Christophe Meyer

27Patents
6h-index
64Co-inventors
68Inventor score

Filing activity: Mar 18, 2003 → Nov 12, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US8299256B2 Quinolinone derivatives as PARP and TANK inhibitors Chemistry; Metallurgy 16 Active
US7241777B2 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors Chemistry; Metallurgy 10 Expired
US8404713B2 Quinolinone derivatives as PARP inhibitors Chemistry; Metallurgy 7 Active
US7943635B2 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors Chemistry; Metallurgy 7 Active
US10077261B2 Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer Chemistry; Metallurgy 7 Active
US8404683B2 Inhibitors of the interaction between MDM2 and P53 Chemistry; Metallurgy 6 Active
US7834016B2 Inhibitors of the interaction between MDM2 and p53 Chemistry; Metallurgy 4 Active
US7449463B2 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication Chemistry; Metallurgy 4 Expired
US8778966B2 Quinolinone derivatives as PARP and tank inhibitors Chemistry; Metallurgy 2 Active
US8377961B2 Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53 Human Necessities 2 Active
US8889866B2 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors Chemistry; Metallurgy 1 Active
US8168644B2 Quinazolinone derivatives as tubulin polymerization inhibitors Chemistry; Metallurgy 1 Active
US9150540B2 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors Chemistry; Metallurgy 1 Active
US8088795B2 Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and p53 Human Necessities 1 Active
US8232298B2 Inhibitors of the interaction between MDM2 and P53 Chemistry; Metallurgy 1 Active
US9527798B2 Cyclopropylboronic compounds, preparation process thereof and use thereof Chemistry; Metallurgy 0 Active
US8883837B2 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication Chemistry; Metallurgy 0 Active
US9598396B2 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors Chemistry; Metallurgy 0 Active
US8278455B2 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication Chemistry; Metallurgy 0 Active
US10526316B2 Quinoxaline and pyridopyrazine derivatives as PI3Kβ inhibitors Chemistry; Metallurgy 0 Active
US11130751B2 Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors Chemistry; Metallurgy 0 Active
US10202387B2 Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors Chemistry; Metallurgy 0 Active
US10894793B2 Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors Chemistry; Metallurgy 0 Active
US10087187B2 Imidazopyridazine derivatives as PI3KB inhibitors Chemistry; Metallurgy 0 Active
US11267804B2 (R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxaline-6-carboxamide for inhibiting phosphoinositide-3-kinase activity Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.